The EXIT project kicked off during a one-day meeting at Leiden University in Leiden, the Netherlands on 30th April 2018. The three-year project will develop a novel nanofluidic device for the isolation of exosomes from bodily fluids and will use this device in the investigation of the metabolic, proteomic, immunologic and transcriptional changes in Alzheimer’s disease.
The project partners got together in Leiden for the project’s first meeting. The project goals and scientific aspects were discussed in all technical details. The meeting focused on the key first steps of the project and establishing efficient internal communication between the project partners.